Brief: AnaptysBio Q3 net income USD -37.308 million
02/11/2023 20:29
Nov 2 (Reuters) - AnaptysBio Q3 collaboration revenue USD 3.318 million. * Q3 operating expenses USD 41.05 million * Q3 income from operations USD -37.732 million * Q3 net income USD -37.308 million
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged